European Archives - Page 988 of 1370 - European Medical Journal

This site is intended for healthcare professionals

Continue
1 Mins
28 May 2019

Efficacy of Oral Thrombopoietin Receptor Agonist Lusutrombopag in Chronic Liver Disease by Underlying Disease Aetiology

Among patients with chronic liver disease (CLD), thrombocytopenia (TCP) is a frequent complication.1,2 Before invasive procedures and surgery in CLD…
6 Mins
28 May 2019

Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different non-invasive imaging modalities…
7 Mins
28 May 2019

Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy

The role of angiopoietin 2 (Ang-2) in HCV-related nephropathy and its relationship with platelet parameters and thrombopoietin (TPO) is evaluated in this…
2 Mins
28 May 2019

A Comparison of Currently Available Direct-Acting Antiviral Hepatitis C Virus Therapy in Canada: On the Path to Elimination

As many as 250,000 Canadians are living with hepatitis C virus (HCV) infection,1 and specific populations, such as people who use drugs (PWUD)…
2 Mins
28 May 2019

The NIACE Score: A Prognostic Indicator in Hepatocellular Carcinoma

The NIACE score is an easy-to-calculate  prognostic score, and this study demonstrated that NIACE can distinguish between two subgroups with different…
9 Mins
28 May 2019

Overlap Syndrome with Autoimmune Hepatitis and Primary Sclerosing Cholangitis

The autoimmune liver diseases (AILD) have been categorised classically as either autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC)…
2 Mins
28 May 2019

L-carnitine Could Be Beneficial in Nonalcoholic Fatty Liver Disease Patients by Improving Choline Metabolism and Reducing Liver Biomarkers

This study investigated what effect L-carnitine supplementation could have on liver metabolites. In this study, the authors hypothesised that L-carnitine…
3 Mins
28 May 2019

miRNA-21 Ablation in Mice Protects Against Gut Microbiota Dysbiosis During Cholestasis

Gut microbiota play an important role in gut–liver axis homeostasis. The understanding of the gut–liver relationship is crucial for the advances of…
13 Mins
28 May 2019

Liver Fibrosis: A Clinical Update

Liver fibrosis is the common sequelae of chronic insult to the liver from any aetiology. The most common causes are alcohol-related, fatty liver disease…
1 Mins
28 May 2019

The Good Use of Paracetamol: Prospective Assessment of the Knowledge of Prescribers, Pharmacists, Care Providers, and Students in a University Medical Centre

The knowledge regarding the proper use of paracetamol is insufficient for the maximum chronic dosage, the risk of paracetamol hepatotoxicity…
We’ve noticed you’re accessing
from North/South America.